• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Immusoft

edit

Immusoft is a Seattle-based biotechnology company that is commercializing technology to program the human immune system by modifying the DNA in immune cells. The core components of Immusoft’s Immune System Programming (ISP™) technology were developed in the Baltimore Lab at the California Institute of Technology (Caltech) and exclusively licensed by Immusoft.

Recent Milestones

edit

• 
  Immusoft received $350k in Grant funding. (4/21/12)
  Posted 4/22/12 at 6:35pm via finsmes.com
• 
  Immusoft added Douglas Sanders as Advisory Board.
  Posted 6/5/13 at 2:46am
• 
  Immusoft added Xim M. Luo as Advisor.
  Posted 6/5/13 at 2:48am
• 
  Immusoft added Hans Peter Kiem as Advisor.
  Posted 6/5/13 at 2:48am
• 
  Immusoft added Shelly Heimfeld as Advisor.
  Posted 6/5/13 at 2:46am
• 
  Immusoft added Iqbal Grewal as Advisor.
  Posted 6/5/13 at 2:46am
• 
  Immusoft added Francois Loic Cosset as Advisor.
  Posted 6/5/13 at 2:46am
• 
  Immusoft added Donna Matuizek as Advisory Board.
  Posted 6/5/13 at 2:46am
• 
  Immusoft added Daniel F. Hoth as Advisory Board.
  Posted 6/5/13 at 2:46am
• 
  Immusoft added Allene Dodge as Advisory Board.
  Posted 6/5/13 at 2:46am
• 
  Immusoft added Richard Chin as Advisory Board.
  Posted 6/5/13 at 2:46am
• 
  Immusoft added Cliona Rooney as Advisor.
  Posted 6/5/13 at 2:48am
• 
  Immusoft added Randall Schatzman as Advisory Board.
  Posted 6/5/13 at 2:46am
• 
  Immusoft added Alan Leong as Advisory Board.
  Posted 6/5/13 at 2:46am
• 
  Immusoft added Stephen Hilbert as Advisory board .
  Posted 6/5/13 at 2:46am
• 
  Immusoft added Perry Fell as Advisory Board.
  Posted 6/5/13 at 2:46am

Videos

Screenshots

edit

Sources

1. Immusoft Receives up to $350K Grant (finsmes.com) [edit]